GJEPC: Plain Gold Jewellery Exports Shine Bright, Grew 27.45% in April-Awfis Space Solutions Limited Rs 599 Crore IPO Opens on 22 May 2024 Price Band Fixed At Rs 364–383 Per Share-Power Finance Corporation Limited (PFC) Announces Q4FY’24 And 12M FY’24 Annual Financial Results For The Period Ended 31st March 2024 Net profit Rises 23% To Rs 7,556 cr-Mukka Proteins net profit stood at Rs 29.15 Crores for the quarter ended March 31, 2024-Shri Harsh Baweja Appointed As Director (Finance) Of REC Limited-DHANASHREE URGES TO ‘HIT A 5’ WITH HER RECENT "#OOTD" Cricket is all about the 4’s and 6’s but what’s “HIT A 5?”-Worried about frizzy hair this summer? Try this DIY hair mask for soft and nourished hair-Exim Bank Reports Stellar Performance, Post's 62% growth in profit, Corporate loan book records 49% y-o-y growth; Loan assets grow by 17%-बँक ऑफ बडोदा’च्या वतीने 31 मार्च 2024 रोजी संपणाऱ्या तिमाही आणि वित्तीय वर्षाचे आर्थिक निकाल घोषित-Union Bank of India Announces Q4FY24 and 12M FY24 Results: Net Profit Soars 19% At Rs 3310 Crores on Lower Provisions; NII Up 14%; Declares 36% Dividend

#COVIFOR

BUSINESS, Corporate, Finance, HOME, Hospital, Health & Pharma, INDUSTRY, Investment, NATION, NEW PRODUCT LAUNCH, PHOTO NEWS, Research & Analysis, STATE June 21, 2020

Hetero announces the approval and launch of first generic ‘COVIFOR’ (Remdesivir) in India for the treatment of Covid-19

MUMBAI, INDIA, 21st JUNE, 2020 (GPN): Hetero, one of India’s leading generic pharmaceutical companies, announced today that it has received the manufacturing and marketing approval for the investigational antiviral medicine ‘Remdesivir’ from the Drug Controller General of…